SCHEMBL9348203

SCHEMBL9348203

O=C1c2cccnc2N(c2cccc(O)c2)C(=O)C12CCCC2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
ESR1 P03372 1/20 0.39
MEN1 O00255 5/20 0.38
KMT2A Q03164 5/20 0.38
ALDH1A1 P00352 4/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
USP2 O75604 1/20 0.38
TNNI3 P19429 1/20 0.38
HTT P42858 1/20 0.38
TNNT2 P45379 1/20 0.38
TNNC1 P63316 1/20 0.38
TLR9 Q9NR96 1/20 0.38
KDM4E B2RXH2 2/20 0.38
POLB P06746 1/20 0.38
FABP1 P07148 1/20 0.38
MAPT P10636 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HPGD P15428 2/20 0.36
CASP1 P29466 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9352368 0.87 PGR (0.42) MEN1KMT2AALDH1A1L3MBTL1KDM4E
SCHEMBL9348254 0.85 PGR (0.43) MEN1KMT2AALDH1A1HTTPGR
SCHEMBL9348232 0.84 MGLL (0.42) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL9348086 0.81 PGR (0.44) NPC1RAB9AALDH1A1POLBMAPT
SCHEMBL9348228 0.80 PGR (0.55) MEN1KMT2AMAPTHPGDPGR
SCHEMBL9348253 0.80 POLB (0.44) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL9629185 0.70 PGR (0.36) MEN1KMT2AALDH1A1L3MBTL1KDM4E
SCHEMBL9628950 0.68 MAPT (0.38) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL24026848 0.68 CACNA2D1 (0.54)
SCHEMBL9628874 0.66 EGLN1 (0.36) MEN1KMT2AALDH1A1L3MBTL1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0338010-B1 PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF HYPERPROLIFERATE SKIN DISEASE SCHERING CORPORATION (US) 1992-02-05 EP claimed
EP-0228416-B1 PHARMACEUTICAL COMPOSITIONS CONTAINING AZANAPHTHALENES SCHERING CORPORATION (US) 1990-03-21 EP claimed
EP-0144996-B1 SUBSTITUTED SPIRO PYRIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THE PREPARATION OF SUCH COMPOUNDS AND COMPOSITIONS SCHERING CORPORATION (US) 1990-02-28 EP claimed
EP-0144996-A2 Substituted spiro pyridine derivatives, pharmaceutical compositions containing them and processes for the preparation of such compounds and compositions SCHERING CORPORATION (US) 1985-06-19 EP claimed
US-5350755-A Treatment of psoriasis or eczema with naphthyridine derivative SCHERING CORPORATION (US) 1994-09-27 US disclosed
EP-0144996-B1 SUBSTITUTED SPIRO PYRIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THE PREPARATION OF SUCH COMPOUNDS AND COMPOSITIONS SCHERING CORPORATION (US) 1990-02-28 EP disclosed
US-4652564-A Substituted spiro pyridine derivatives as anti-allergy and antiinflammatory agents SCHERING CORPORATION (US) 1987-03-24 US disclosed
EP-0144996-A2 Substituted spiro pyridine derivatives, pharmaceutical compositions containing them and processes for the preparation of such compounds and compositions SCHERING CORPORATION (US) 1985-06-19 EP disclosed